Tokushima, Japan

Koichi Ogino

This inventor holds 3 USPTO granted patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2004-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Koichi Ogino. Retrieved from https://idiyas.com/inventor/koichi-ogino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Naruto, JP (2004)
  • Tokushima, JP (2008 - 2011)

Company Filing History:


Years Active: 2004-2011

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Koichi Ogino: Innovator in GD3-Mimetic Peptides

Introduction

Koichi Ogino is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of GD3-mimetic peptides. With a total of 3 patents, his work has garnered attention for its potential applications in therapeutic compositions.

Latest Patents

Ogino's latest patents focus on GD3-mimetic peptides. These peptides contain an amino acid sequence represented by any of SEQ ID NOS: 1 to 4 or an amino acid sequence derived therefrom by substitution, deletion, addition, or insertion of one or more amino acid residues. They are designed to attain specific binding to an anti-GD3 antibody, along with medicinal compositions containing the same.

Career Highlights

Koichi Ogino is currently associated with Otsuka Pharmaceutical Company, Limited. His role at the company allows him to further his research and development efforts in the pharmaceutical industry. His innovative work has the potential to impact various therapeutic areas.

Collaborations

Ogino collaborates with esteemed colleagues such as Dai Ishikawa and Takao Taki. Their combined expertise contributes to the advancement of research in their field.

Conclusion

Koichi Ogino's contributions to the development of GD3-mimetic peptides highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for innovative therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…